Home >> Investigator Page Previous      Next
Bhawna Sirohi, M.B.B.S., D.C.H, M.R.C.P.
Medical Oncologist 
Tata Memorial Hospital
GI and Breast Unit
Mumbai - 400 012   
Positions Held:
Position Affiliation Time Period
Head of Department Artemis Health Institute, Gurgaon, India 2010-2012
Director Max Healthcare, New Delhi, India 2009
Consultant Royal Marsden Hospital, London, UK
Area of Specialization:
Medical Oncology
1. Sirohi B.  Cancer management in the twenty-first century in India. Indian Journal of Medical and Paediatric Oncology. 2010.  31, 49-50. [PubMed]
2. Sirohi B.  New Delhi metallo-beta-lactamase 1. The Lancet Infectious Diseases. 2010.  10, 750; author reply 752-752. [PubMed]
3. Cook, N., Basu, B., Biswas, S., Kareclas, P., Mann, C., Palmer, C., Thomas, A., Nicholson, S., Morgan, B., Lomas, D., Sirohi, B., Mander, A. P., Middleton, M. and Corrie, P. G.  A phase 2 study of vatalanib in metastatic melanoma patients. European Journal of Cancer. 2010.  46, 2671-2673. [PubMed]
4. Powles, R., Sirohi, B. and Niederwieser, D.  The role of the European haematologist in a large irradiation emergency: the European Blood and Marrow Transplantation Society (EBMT) Nuclear Accident Committee (NAC). Health Physics. 2010.  98, 810-814. [PubMed]
5. Basu, B., Sirohi, B. and Corrie, P.  Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin. Endocrine-related Cancer. 2010.  17, R75-90. [PubMed]
6. Basu, B., Biswas, S., Wrigley, J., Sirohi, B. and Corrie, P.  Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies. Expert Review of Anticancer Therapy. 2009.  9, 1583-1598. [PubMed]
7. Sirohi, B. and Powles, R.  Lenalidomide in multiple myeloma. Expert Review of Anticancer Therapy. 2009.  9, 1559-1570. [PubMed]
8. Sirohi, B., Leary, A. and Johnston, S. R.  Ipsilateral breast tumor recurrence: is there any evidence for benefit of further systemic therapy? The Breast Journal. 2009.  15, 268-278. [PubMed]
9. Fliedner, T. M., Chao, N. J., Bader, J. L., Boettger, A., Case, C., Chute, J., Confer, D. L., Ganser, A., Gorin, N. C., Gourmelon, P., Graessle, D. H., Krawisz, R., Meineke, V., Niederwieser, D., Port, M., Powles, R., Sirohi, B., Weinstock, D. M., Wiley, A. and Coleman, C. N.  Stem cells, multiorgan failure in radiation emergency medical preparedness: a U.S./European Consultation Workshop. Stem Cells. 2009.  27, 1205-1211. [PubMed]
10. Sirohi, B., Powles, R., Singhal, S., Smith, K., Jones, R. L., Saso, R., Kulkarni, S., Treleaven, J., Swansbury, G. J., Potter, M., Morgan, G. and Mehta, J.  Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotype. Leukemia & Lymphoma. 2008.  49, 2284-2290. [PubMed]
11. Sirohi, B. and Smith, K.  Bevacizumab in the treatment of breast cancer. Expert Review of Anticancer Therapy. 2008.  8, 1559-1568. [PubMed]
12. Fliedner, T. M., Powles, R., Sirohi, B. and Niederwieser, D.  Radiologic and nuclear events: the METREPOL severity of effect grading system. Blood. 2008.  111, 5757-5765. [PubMed]
13. Leary, A. F., Sirohi, B. and Johnston, S. R.  Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer. Breast Cancer Research. 2007.  9, 112. [PubMed]
14. Sirohi, B., Ashley, S., Norton, A., Popat, S., Hughes, S., Papadopoulos, P., Priest, K. and O'Brien, M.  Early response to platinum-based first-line chemotherapy in non-small cell lung cancer may predict survival. Journal of Thoracic Oncology. 2007.  2, 735-740. [PubMed]
15. Sirohi, B., Cunningham, D., Norman, A., Last, K., Chau, I., Horwich, A., Oates, J., Chong, G. and Wotherspoon, A.  Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL). Hematology. 2007.  12, 149-153. [PubMed]
16. Sirohi, B., Powles, R., Cavanagh, J., Oakervee, H., Dyer, P., Rintala, T., Kulkarni, S., Rudin, C., Horton, C., Treleaven, J. and Morgan, G.  Collection of peripheral blood stem cells in new patients with myeloma receiving minimal or no prior cytoreductive therapy. Hematology. 2007.  12, 113-115. [PubMed]
17. Murphy, F., Sirohi, B. and Cunningham, D.  Stem cell transplantation in Hodgkin lymphoma. Expert Review of Anticancer Therapy. 2007.  7, 297-306. [PubMed]
18. Arkenau, H. T., Chong, G., Cunningham, D., Watkins, D., Sirohi, B., Chau, I., Wotherspoon, A., Norman, A., Horwich, A. and Matutes, E.  Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience. Haematologica. 2007.  92, 271-272. [PubMed]
19. Sirohi, B. and Powles, R.  Epidemiology and outcomes research for MGUS, myeloma and amyloidosis. European Journal of Cancer. 2006.  42, 1671-1683. [PubMed]
20. Bird, J. M., Fuge, R., Sirohi, B., Apperley, J. F., Hunter, A., Snowden, J., Mahendra, P., Milligan, D., Byrne, J., Littlewood, T., Fegan, C., McQuaker, G., Pagliuca, A., Johnson, P., Rahemtulla, A., Morris, C. and Marks, D. I.  The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation study. British Journal of Haematology. 2006.  134, 385-390. [PubMed]
21. Sirohi, B., Powles, R., Rudin, C., Singhal, S., Kulkarni, S., Saso, R., Horton, C., Mehta, J. and Treleaven, J.  Re-use of the original infusional induction chemotherapy as salvage therapy in myeloma patients relapsing after one autograft. Hematology. 2005.  10, 361-364. [PubMed]
22. Prescot, A. P., Dzik-Jurasz, A. S., Leach, M. O., Sirohi, B., Powles, R. and Collins, D. J.  Localized COSY and DQF-COSY 1H-MRS sequences for investigating human tibial bone marrow in vivo and initial application to patients with acute leukemia. Journal of Magnetic Resonance Imaging. 2005.  22, 541-548. [PubMed]
23. Vaidya, S. J., Ortin, M., Lopez-Duarte, M., Sirohi, B., Powles, R., Treleaven, J. and Richard, C.  Haemopoietic progenitor cell transplantation in patients with previous history of invasive fungal infection. Leukemia & Lymphoma. 2005.  46, 1143-1150. [PubMed]
24. Alvares, C. L., Davies, F. E., Horton, C., Patel, G., Powles, R., Sirohi, B., Zuha, R., Gatt, A., Saso, R., Treleaven, J. G., Dearden, C. E., Potter, M. N., Ethell, M. E. and Morgan, G. J.  Long-term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high-dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatments. British Journal of Haematology. 2005.  129, 607-614. [PubMed]
25. Pearson, I. C., Sirohi, B., Powles, R., Treleaven, J. and Mortimer, P. S.  The impact on resources of prevalence and nature of skin problems in a modern intensive haemato-oncology practice. Hematology. 2004.  9, 415-423. [PubMed]
26. Sirohi, B. and Powles, R.  Multiple myeloma. Lancet. 2004.  363, 875-887. [PubMed]
27. Durie, B. G., Kyle, R. A., Belch, A., Bensinger, W., Blade, J., Boccadoro, M., Child, J. A., Comenzo, R., Djulbegovic, B., Fantl, D., Gahrton, G., Harousseau, J. L., Hungria, V., Joshua, D., Ludwig, H., Mehta, J., Morales, A. R., Morgan, G., Nouel, A., Oken, M., Powles, R., Roodman, D., San, M., Shimizu, K., Singhal, S., Sirohi, B., Sonneveld, P., Tricot, G. and Van, N.  Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. The Hematology Journal. 2003.  4, 379-398. [PubMed]
28. Shaw, B. E., Peggs, K., Bird, J. M., Cavenagh, J., Hunter, A., Alejandro, M., Russell, N. H., Sirohi, B., Towlson, K., Williams, C. D. and Marks, D. I.  The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma. British Journal of Haematology. 2003.  123, 886-895. [PubMed]
29. Elnenaei, M. O., Gruszka-Westwood, A. M., A'Hernt, R., Matutes, E., Sirohi, B., Powles, R. and Catovsky, D.  Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and CDKN2A. Haematologica. 2003.  88, 529-537. [PubMed]
30. Powles, R., Sirohi, B., Treleaven, J., Kulkarni, S., Tait, D., Singhal, S. and Mehta, J.  The role of posttransplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukemia. Blood. 2002.  100, 1641-1647. [PubMed]


Book Chapters:
Editor – Indian Journal of Medical and Paediatric Oncology (IJMPO)
Editor – Health Positive
Reviewer for The Lancet, Annals of Oncology , IJMPO, Indian Journal of Cancer , JCRT
My CV:   Download
M.B.B.S. Lala Lajpat Rai Memorial Medical College, Meerut, India
D.C.H Lala Lajpat Rai Memorial Medical College, Meerut, India
Secretary, EBMT Nuclear Accident Committee
American Society of Clinical Oncology
American Society of Hematology
European School of Medical Oncology
Chronic Leukaemia Working Party of EBMT
Multiple Myeloma Working sub-Committee of EBMT
European Haematology Association
British Society for Blood and Marrow Transplantation
Association of Cancer Physicians, UK
Indian Cooperative Oncology Network
Indian Society of Medical and Pediatric Oncology
Type of Neoplasms
Pulmonary system
Hemato-lymphoid system
Lymph nodes
  Last modified on : Dec 9, 2015
India Cancer Research Database has been developed by the Institute of Bioinformatics with funding from the Department of Biotechnology, Government of India.